New tactics against tuberculosis.
Barry
Clifton E
CE
National Institutes of Health, Institute of Allegrey and Infestious Diseases (NIAID), USA.
Cheung
Maija S
MS
D000995:Antitubercular Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004196:Disease Outbreaks; D015195:Drug Design; D004352:Drug Resistance, Microbial; D049672:History, 19th Century; D049673:History, 20th Century; D049674:History, 21st Century; D049690:History, Ancient; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000235:genetics / Q000254:growth & development; D014376:Tuberculosis; D032581:Tuberculosis Vaccines; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000453:epidemiology* / Q000266:history
D000995:Antitubercular Agents; D032581:Tuberculosis Vaccines